FDA inspection
Shilpa Medicare Limited: FDA inspection ending Feb 25, 2020
FDA inspection 1121634 · Official Action Indicated (OAI) · Jadcherla, Mahabubnagar District
Key facts
| Inspection ID | 1121634 |
|---|---|
| Firm | Shilpa Medicare Limited |
| FEI number | 3009876430 |
| Address | S-20 To S-26, Pharm. Formulation Sez, Tsiic, Green Industrial Park |
| City | Jadcherla, Mahabubnagar District |
| Country | India |
| Fiscal year | 2020 |
| Inspection end date | Feb 25, 2020 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 607877 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data